Pharmasig is a company specialized in the development of new businesses for the Brazilian pharmaceutical sector, acting in the registration of new medicines with ANVISA up to the importation and distribution throughout the national territory. Our main goal is to bring new medicines to the Brazilian market through partnerships with foreign companies.

Pharmasig is a company that has all the authorizations required by ANVISA for the registration, importation, storage, distribution and commercialization of medicines, cosmetics and health products in Brazil.

We have all the legal requirements to operate: storage, billing, quality control, microbiological laboratory and central office.

Expertise in the market segments: (institutional, OTC, orphan drugs and retail), regulatory, supply chain and NBD. Training in the following areas: commercial, regulatory and quality, operations and logistics and new business development. Due to the management team’s vast market experience, operating costs are kept at reduced levels.

Pharmasig operates in the following business areas:

IMPORTED PRODUCTS

Pharmasig, due to its international partnerships, has the following products that can be directly imported from their respective manufacturers.

DEVELOPMENT OF NEW BUSINESS

Pharmasig is a company experienced in establishing international partnerships that aim at registering, importing, and marketing medicines in the Brazilian market. The company understands that Brazil is a great store of business opportunities since it is among the main pharmaceutical markets in the world, on the other hand, the country presents unique technical complexities and a particular market dynamic. Therefore, it is fundamental for pharmaceutical companies from other countries to have at their disposal the structure and expertise of a company like Pharmasig to launch their medicines quickly, reliably and with low risk in the Brazilian market.

Pharmasig is a company founded by executives from large multinationals in the pharmaceutical sector, where they have held management and board positions in the most diverse areas, including commercial, marketing, regulatory, operations, and new business. Thus, the company has a strong knowledge accumulated over more than 80 years that all its executives have been active in the pharmaceutical market, and which it makes available to its commercial partners. Among the main achievements of this executive team are the registration and launch of several first copies of off-patent drugs and, also, the approval of numerous manufacturing plants abroad by ANVISA.

In addition, Pharmasig has all the structure required by ANVISA already approved and operational to register, import, and market drugs (including controlled ones) and cosmetics in Brazil. So, we have a quality control laboratory, including a microbiological lab, warehouse, receiving and dispatch area, as well as a central office.

In short, Pharmasig is ready to establish long-term strategic partnerships with foreign companies aiming at new business development in Brazil and offering the partner excellent technical support, speed, flexibility, low implementation cost, low risk, and, above all, ethics.